Blogs

People who regularly eat foods with a low nutritional quality have a higher risk of developing cancer. “This should come as a surprise to no one. Doctors, researchers, nutritionists have been saying this for decades,” said John F. Sacco, MD,   (Read More)

September is recognized as Gynecologic Cancer Awareness Month, and OHC (Oncology Hematology Care), a leading provider of advanced comprehensive cancer care is spreading the word that every woman is at risk for developing a gynecologic cancer. OHC is   (Read More)

Cancer never rests — and neither do those who have devoted their lives to finding new ways to battle this disease. There are so many exciting new findings being discovered every day in cancer research. Here is a brief summary of some of the most   (Read More)

Nelson Mandela said education is the most powerful weapon which you can use to change the world. This is especially true when it comes to cancer. The more we know about cancer and how lifestyle choices affect our risk of getting it, the better our   (Read More)

This month organizations across the world will honor the patients, their families, researchers, doctors and all those immersed in the treatment of blood cancers through activities associated with Lymphoma Awareness Month, Leukemia Awareness Month,   (Read More)

September is Gynecologic Cancer Awareness Month, a national recognition established by the Foundation for Women’s Cancer in 1999. It is estimated that this year 98,000 women will be diagnosed with a gynecologic cancer and some 30,000 will die from   (Read More)

On August 17, 2018 the FDA approved the first immunotherapy – the checkpoint inhibitor nivolumab (Opdivo) – for patients with small cell lung cancer (SCLC). This approval provides an important treatment option for patients with metastatic SCLC   (Read More)

Today, OHC’s James H. Essell, MD, a leading authority on blood and marrow transplant and a national expert leading the CAR T-cell therapy program for The US Oncology Network, was invited to spend time with emergency medicine residents at the   (Read More)

A lump in the breast is just one of the possible signs of breast cancer in men or women. Sometimes there may be signs and symptoms of breast cancer without a noticeable lump in the breast. These symptoms may not be caused by cancer, but they might   (Read More)

Each year OHC (Oncology Hematology Care) and Cancer Support Community (CSC) bring together four “chefs” for fun, laughter and education as they battle their way to become the new Cancer Chopped Champion! This year marks the third annual Cancer   (Read More)

The average age of people diagnosed with cancer of the kidneys (renal cell carcinoma) is 64. Once diagnosed, if caught early, the five-year survival rate is 81%. But, if the cancer is caught at a later stage, survival rates plummet to less than 10%.   (Read More)

Anaplastic thyroid cancer is one of the least common but most aggressive forms of thyroid cancer. Add to that, it’s resistance to cancer treatments. Patients diagnosed with the disease have an average lifespan of about five months after diagnosis.   (Read More)

Michele’s sister was diagnosed with colon cancer at age 33. Because her sister was so young, Michele’s doctor suggested she have a colonoscopy. The surgeon removed three pre-malignant tumors. Michele considers her sister and her doctors   (Read More)

OHC (Oncology Hematology Care) is partnering with the David Benzer Strike Out Fear Foundation and the Cincinnati Reds to help local cancer patients reduce their fear and anxiety as they face cancer. David Benzer was a long-time member of the   (Read More)

I am a radiation oncologist who works with a team of cancer experts to treat patients with cancer. I’m also board certified in Integrative and Holistic Medicine, which means I believe in a person-centered, team-based approach to health care. One   (Read More)